Search For "bharat biotech"
Bharat Biotech's intranasal heterologous booster dose likely to hit market
Updated : 3 years, 2 months ago IST
According to the company, the price of iNCOVACC will be Rs 900 for the private market and Rs 325 for supplies to the Government of India and State Governments.
Read More
Ocugen announces positive top-line data for Covaxin in US trials
Updated : 3 years, 2 months ago IST
A release said that Covaxin has been demonstrated in clinical trials to generate a broader immune response "against the whole virus covering important antigens such as S-protein, RBD, and N-protein whereas currently approved vaccines in the US target only S-protein antigen"
Read More
Bharat Biotech's nasal Covid vaccine to be priced at Rs 800 for private an
Updated : 3 years, 2 months ago IST
Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which was given approval as a booster dose, will be priced at Rs 800 plus GST in private hospitals..
Read More
Bharat Biotech's nasal Covid vaccine for adults gets Centre's nod, to be a
Updated : 3 years, 3 months ago IST
Bharat Biotech's nasal vaccine - iNCOVACC has been approved by the Government of India and will be used as a heterologous booster dose for those above 18 years of age
Read More
World's first intra-nasal vaccine for COVID gets CDSCO nod for restricted
Updated : 3 years, 3 months ago IST
The Central Drugs Standard Control Organization (CDSCO) has approved India's first intra-nasal vaccine for COVID for restricted use in emergency situations in people aged 18 and up.
Read More
India-made iNCOVACC, world's first intra-nasal vaccine to receive approval
Updated : 3 years, 3 months ago IST
iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced
Read More
Government rejects claims of rushed approval for Covaxin due to 'political
Updated : 3 years, 4 months ago IST
The reports claimed that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine - Covaxin, "had to skip certain processes" and "speed" up clinical trials due to political pressure. The reports further claimed that there were several irregularities in the three phases of the clinical
Read More
DCGI's subject expert committee to hold discussion on 'Five Arms' intranas
Updated : 3 years, 4 months ago IST
DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in September this year applied for DCGI's approval for market authorization of its "Five Arms" intranasal heterologous booster dose, and it has now announced that iNCOVACC (BBV154) has re
Read More
Bharat Biotech applies for market authorisation from DCGI for five arms in
Updated : 3 years, 6 months ago IST
New Delhi [India], September 11 (ANI): Bharat Biotech has applied for market authorisation from the Drugs Controller General of India (DCGI) for intranasal heterologous booster, sources told ANI.
Read More
Bharat Biotech-made iNCOVACC becomes world's first intranasal COVID vaccin
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Drugs Controller General of India (DCGI) rendered an emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine- iNCOVACC, said officials on Tuesday.
Read More
COVID-19: India's first intranasal vaccine by Bharat Biotech gets DCGI app
Updated : 3 years, 6 months ago IST
New Delhi [India], September 6 (ANI): The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
Read More
Nigeria introduces Bharat Biotech's Rotavac vaccine to immunise children
Updated : 3 years, 7 months ago IST
Hyderabad (Telangana) [India], August 24 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and bio-therapeutics manufacturer, on Wednesday announced that its rotavirus oral vaccine ROTAVAC has been introduced to immunise its children from the life-threatening diarrhoeal
Read More